Abstract
Significance:

32
The widespread use of long lasting insecticidal nets (LLINs) and indoor residual spray 33 has selected for mosquitoes that are resistant to pyrethroids or avoid exposure by feeding 34 outdoors or on livestock. Systemic insecticides, drugs that render a host's blood toxic to 35 feeding mosquitoes, could be an effective control strategy for mosquitoes with pyrethroid 36 resistance and/or outdoor feeding tendencies. Here, a number of existing systemic insecticide 
56
To build on recent gains in malaria vector control, it is critical to develop a method 57 that is effective against pyrethroid resistant, outdoor feeding/resting, or zoophagic mosquitoes 58 (9). A promising solution is systemic insecticides, drugs that render host blood toxic to a 59 mosquito that takes a blood meal (10). The types of systemic insecticides most relevant to 60 treating mosquitoes are ectoparasiticides, drugs that target ectoparasites (e.g. blood-feeding 61 arthropods), and endectocides, drugs that target both endo-and ectoparasites. Many Text for model development and Table S1 for parameter values). The proportion of bites that assessed for eligibility, and 139 met the eligibility criteria (Fig. 1a) . The studies reported 198 pharmacokinetic parameters in eight different host categories, ten systemic insecticides, and 199 six routes of administration ( Fig. 1b-d) . The three most commonly studied hosts were cattle, than in other hosts (Fig. 2b, Fig. S4 ). When comparing routes of administration for different 221 hosts, topically applied drugs typically achieved longer half-lives than orally applied ones 222 (Fig. 2c, Fig. S5 ).
223
The significant factors for Cmax were drug (p = 0.03) and interactions between host 224 and drug (p = 0.002) and host and route (p < 0.001). The order of drugs from lowest to
225
highest Cmax was different from that of half-lives: milbemycins < avermectins < isoxazolines
226
< spinosyns (Fig. S6) . Cattle reported the lowest median Cmax for milbemycins, whereas dogs 227 and sheep had the lowest Cmax for avermectins (Fig. 2d, Fig. S7 ). There was also a 228 dependency of Cmax on host and route (Fig. 2e, Fig. S8 (Fig. 3a) . The addition of treating a blood host with 244 systemic insecticide can further reduce malaria prevalence when applied frequently enough.
245
IV. Dosing strategy design and evaluation
246
To quantify the efficacy of different dosing strategies, the relative reduction (RR) in 247 malaria prevalence after three years of using LLINs and systemic insecticide treated livestock 248 was compared to that of using LLINs alone. For a set dosing frequency, the RR increased as a 249 function of half-life and Cmax (Fig. 3b) .
250
The minimum dosing frequency was calculated to achieve a target RR (here, 10%) for 251 a range of different drugs distinguished by half-life, Cmax, 50 , and 50 [ ] (Fig. 3c-i) or >50%, respectively) ( Fig. 4a-c) Choosing the correct control method for a given community also relies on the 311 bloodmeal preference of the mosquito population (Fig. 4d-e identified drugs need to be applied at frequencies much higher than the current MDA's 330 annual or bi-annual dosing regimen (19). For instance, it was estimated that many scenarios 331 using moxidectin would need to be dosed at an unrealistic frequency, faster than once a week,
332
to reduce malaria transmission. This supports previous studies that show moxidectin has little 333 impact on mosquitoes (28) and would not be an effective choice for a treatment strategy.
334
Further investigation of these drugs' safety in hosts and effect on mosquitoes is necessary.
335
To design treatments with an operationally realistic dosing frequency (i.e. once or 336 twice a year), drugs that naturally attain higher blood concentrations and have longer half-337 lives (i.e. isoxazolines and spinosyns) could be selected or alternative ways to achieve higher 
346
In addition to designing a dosing regimen that is effective at reducing the transmission 347 of a vector-borne disease, the secondary effects should also be considered: 
